title: Spectrophotometric, spectrofluorimetric, and densitometric methods for the determination of indapamide.
abstract: Three sensitive spectrophotometric, spectrofluorimetric, and densitometric methods are described for the determination of indapamide. The first and second methods are based on the oxidative coupling reaction of indapamide with 3-methyl-2-benzothiazolinone hydrazone HCl (MBTH) in the presence of cerium(IV) ammonium sulfate in an acidic medium. The absorbance of the reaction product is measured at the lambdamax, 601 nm. With the same reaction, indapamide is determined by its quenching effect on the fluorescence of excess cerous ions at the emission lambdamax, 350 nm, and the excitation at lambdamax, 300 nm. The reaction conditions were optimized, and Beer's law was obeyed for indapamide at 1.2-9.6 microg/mL with mean recoveries of 99.92 +/- 0.83 and 99.97 +/- 1.11%, respectively. The third method, a stability-indicating densitometric assay, was developed for the determination of indapamide, using toluene-ethyl acetate-glacial acetic acid (69 + 30 + 1, v/v/v) as the developing system and scanning at the lambdamax, 242 nm, in the presence of the degradation product and related substance; for the indapamide concentration range of 0.6-6 microg/spot, the mean recovery was 99.73 +/- 0.71%. The proposed methods were successfully applied to the determination of indapamide in bulk powder and commercial tablets, and the results of the analysis agreed statistically with those obtained with the official method. Furthermore, the methods were validated according to the guidelines of the U.S. Pharmacopeia and also assessed by applying the standard additions technique.
authors: National Organization for Drug Control and Research, 6 Abo Hazem St. Pyramids Ave, PO Box 29, Cairo, Egypt. gomagdy@yahoo.com
authors: Nadia F
authors: NF
authors: Youssef
mesh_terms: D000959:Antihypertensive Agents / Q000032:analysis*; D052160:Benzothiazoles; D002563:Cerium / Q000737:chemistry; D003720:Densitometry / Q000379:methods*; D006835:Hydrazones; D006863:Hydrogen-Ion Concentration; D007190:Indapamide / Q000032:analysis*; D007202:Indicators and Reagents; D010084:Oxidation-Reduction; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D012680:Sensitivity and Specificity; D013050:Spectrometry, Fluorescence / Q000379:methods*; D013053:Spectrophotometry / Q000379:methods*; D013431:Sulfates / Q000737:chemistry; D013844:Thiazoles / Q000737:chemistry
chemical_list: D000959:Antihypertensive Agents; D052160:Benzothiazoles; D006835:Hydrazones; D007202:Indicators and Reagents; D004364:Pharmaceutical Preparations; D013431:Sulfates; D013844:Thiazoles; C107379:cerium sulfate; D002563:Cerium; D007190:Indapamide; C002536:3-methyl-2-benzothiazolone hydrazone